{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:48:55Z","timestamp":1791348535729,"version":"4.3.1"},"reference-count":89,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.molmed.2011.05.003","type":"journal-article","created":{"date-parts":[[2011,8,25]],"date-time":"2011-08-25T18:53:43Z","timestamp":1314298423000},"page":"485-493","source":"Crossref","is-referenced-by-count":128,"title":["Exploring the link between glucocerebrosidase mutations and parkinsonism"],"prefix":"10.1016","volume":"17","author":[{"given":"Wendy","family":"Westbroek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Marie","family":"Gustafson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Sidransky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2011.05.003_bib0005","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20676","article-title":"Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)","volume":"29","author":"Hruska","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.molmed.2011.05.003_bib0010","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bcmd.2010.10.007","article-title":"A monozygotic twin pair with highly discordant Gaucher phenotypes","volume":"46","author":"Biegstraaten","year":"2010","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.molmed.2011.05.003_bib0015","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ymgme.2007.10.132","article-title":"Intracellular cholesterol modifies the ERAD of glucocerebrosidase in Gaucher disease patients","volume":"93","author":"Ron","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.molmed.2011.05.003_bib0020","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1136\/jmg.2004.028019","article-title":"Divergent phenotypes in Gaucher disease implicate the role of modifiers","volume":"42","author":"Goker-Alpan","year":"2005","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.molmed.2011.05.003_bib0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ymgme.2004.08.015","article-title":"Gaucher disease: complexity in a \u201csimple\u201d disorder","volume":"83","author":"Sidransky","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.molmed.2011.05.003_bib0030","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/qjmed\/89.9.691","article-title":"Occurrence of Parkinson's syndrome in type I Gaucher disease","volume":"89","author":"Neudorfer","year":"1996","journal-title":"Q. J. Med."},{"key":"10.1016\/j.molmed.2011.05.003_bib0035","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1086\/367850","article-title":"Reciprocal and nonreciprocal recombination at the glucocerebrosidase gene region: implications for complexity in Gaucher disease","volume":"72","author":"Tayebi","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2011.05.003_bib0040","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10545-010-9095-5","article-title":"The neurological manifestations of Gaucher disease type 1: the French Observatoire on Gaucher disease (FROG)","volume":"33","author":"Cherin","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.molmed.2011.05.003_bib0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10545-010-9055-0","article-title":"The risk of Parkinson's disease in type 1 Gaucher disease","volume":"33","author":"Bultron","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.molmed.2011.05.003_bib0050","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1212\/01.wnl.0000230215.41296.18","article-title":"Glucocerebrosidase mutations are an important risk factor for Lewy body disorders","volume":"67","author":"Goker-Alpan","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.molmed.2011.05.003_bib0055","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/jmg.2004.024455","article-title":"Parkinsonism among Gaucher disease carriers","volume":"41","author":"Goker-Alpan","year":"2004","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.molmed.2011.05.003_bib0060","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.bcmd.2006.02.004","article-title":"Increased incidence of Parkinson disease among relatives of patients with Gaucher disease","volume":"36","author":"Halperin","year":"2006","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.molmed.2011.05.003_bib0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ymgme.2003.11.004","article-title":"Glucocerebrosidase mutations in subjects with parkinsonism","volume":"81","author":"Lwin","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.molmed.2011.05.003_bib0070","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa033277","article-title":"Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews","volume":"351","author":"Aharon-Peretz","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2011.05.003_bib0075","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ymgme.2007.03.004","article-title":"Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease","volume":"91","author":"Ziegler","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.molmed.2011.05.003_bib0080","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2011.05.003_bib0085","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/archneurol.2009.72","article-title":"Mutations for Gaucher disease confer high susceptibility to Parkinson disease","volume":"66","author":"Mitsui","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.molmed.2011.05.003_bib0090","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neulet.2009.01.029","article-title":"Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece","volume":"452","author":"Kalinderi","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.molmed.2011.05.003_bib0095","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archneurol.2007.68","article-title":"Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders","volume":"65","author":"Mata","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.molmed.2011.05.003_bib0100","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.neurobiolaging.2007.11.016","article-title":"Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Portugal","volume":"30","author":"Bras","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.molmed.2011.05.003_bib0105","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/brain\/awp044","article-title":"Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease","volume":"132","author":"Neumann","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.molmed.2011.05.003_bib0110","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1212\/01.wnl.0000327823.81237.d1","article-title":"Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset","volume":"72","author":"Nichols","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.molmed.2011.05.003_bib0115","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1212\/01.wnl.0000304039.11891.29","article-title":"Genotype\u2013phenotype correlations between GBA mutations and Parkinson disease risk and onset","volume":"70","author":"Gan-Or","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.molmed.2011.05.003_bib0120","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/mds.20766","article-title":"Glucocerebrosidase mutations are also found in subjects with early-onset parkinsonism from Venezuela","volume":"21","author":"Eblan","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.molmed.2011.05.003_bib0125","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/jnnp.2006.105940","article-title":"Glucocerebrosidase gene mutation is a risk factor for early onset of Parkinson disease among Taiwanese","volume":"78","author":"Wu","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.molmed.2011.05.003_bib0130","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/archneurol.2009.54","article-title":"Association of glucocerebrosidase mutations with dementia with Lewy bodies","volume":"66","author":"Clark","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.molmed.2011.05.003_bib0135","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/mds.23046","article-title":"Gaucher disease ascertained through a Parkinson's center: imaging and clinical characterization","volume":"25","author":"Saunders-Pullman","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.molmed.2011.05.003_bib0140","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/mds.23213","article-title":"Functional brain imaging in glucocerebrosidase mutation carriers with and without parkinsonism","volume":"25","author":"Kono","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.molmed.2011.05.003_bib0145","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00401-010-0711-0","article-title":"The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia","volume":"120","author":"Schulz-Schaeffer","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.molmed.2011.05.003_bib0150","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.2741\/2973","article-title":"Proteomic identification of novel proteins associated with Lewy bodies","volume":"13","author":"Xia","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.molmed.2011.05.003_bib0155","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease","volume":"18","author":"Kruger","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2011.05.003_bib0160","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.molmed.2011.05.003_bib0165","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","article-title":"Genome-wide association study reveals genetic risk underlying Parkinson's disease","volume":"41","author":"Simon-Sanchez","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2011.05.003_bib0170","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molmed.2011.05.003_bib0175","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.bpj.2010.07.056","article-title":"Effects of curvature and composition on alpha-synuclein binding to lipid vesicles","volume":"99","author":"Middleton","year":"2010","journal-title":"Biophys. J."},{"key":"10.1016\/j.molmed.2011.05.003_bib0180","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.1195227","article-title":"alpha-Synuclein promotes SNARE-complex assembly in vivo and in vitro","volume":"329","author":"Burre","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.molmed.2011.05.003_bib0185","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00401-010-0741-7","article-title":"Glucocerebrosidase is present in alpha-synuclein inclusions in Lewy body disorders","volume":"120","author":"Goker-Alpan","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.molmed.2011.05.003_bib0190","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","article-title":"Neuropathology provides clues to the pathophysiology of Gaucher disease","volume":"82","author":"Wong","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.molmed.2011.05.003_bib0195","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/hmg\/ddi240","article-title":"ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity","volume":"14","author":"Ron","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2011.05.003_bib0200","article-title":"Characterization of the ERAD process of the L444P mutant glucocerebrosidase variant","author":"Bendikov-Bar","year":"2010","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.molmed.2011.05.003_bib0205","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nchembio850","article-title":"Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease","volume":"3","author":"Lieberman","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.molmed.2011.05.003_bib0210","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1021\/cb600187q","article-title":"Chemical chaperones and permissive temperatures alter localization of Gaucher disease associated glucocerebrosidase variants","volume":"1","author":"Sawkar","year":"2006","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.molmed.2011.05.003_bib0215","doi-asserted-by":"crossref","DOI":"10.1002\/ana.22400","article-title":"Acid beta-glucosidase mutants linked to Gaucher disease Parkinson disease, and Lewy body dementia alter alpha-synuclein processing","author":"Cullen","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molmed.2011.05.003_bib0220","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/13506120802193746","article-title":"Do amyloid oligomers act as traps for misfolded proteins? A hypothesis","volume":"15","author":"Gruschus","year":"2008","journal-title":"Amyloid"},{"key":"10.1016\/j.molmed.2011.05.003_bib0225","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nn.2575","article-title":"Autophagy gone awry in neurodegenerative diseases","volume":"13","author":"Wong","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.molmed.2011.05.003_bib0230","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","article-title":"Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy","volume":"305","author":"Cuervo","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.molmed.2011.05.003_bib0235","doi-asserted-by":"crossref","first-page":"13621","DOI":"10.1074\/jbc.M109.074617","article-title":"Lysosomal degradation of alpha-synuclein in vivo","volume":"285","author":"Mak","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2011.05.003_bib0240","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1001\/archneurol.2010.198","article-title":"Chaperone-mediated autophagy markers in Parkinson disease brains","volume":"67","author":"Alvarez-Erviti","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.molmed.2011.05.003_bib0245","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/187152410791196350","article-title":"Targeting autophagy in the brain: a promising approach?","volume":"10","author":"Santos","year":"2010","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.molmed.2011.05.003_bib0250","doi-asserted-by":"crossref","first-page":"13578","DOI":"10.1523\/JNEUROSCI.4390-09.2009","article-title":"Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases","volume":"29","author":"Spencer","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2011.05.003_bib0255","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/hmg\/ddm100","article-title":"Autophagy in Niemann-Pick C disease is dependent upon Beclin-1 and responsive to lipid trafficking defects","volume":"16","author":"Pacheco","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2011.05.003_bib0260","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/hmg\/ddq204","article-title":"Saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting","volume":"19","author":"Vaccaro","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2011.05.003_bib0265","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/hmg\/ddp580","article-title":"Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits","volume":"19","author":"Sun","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2011.05.003_bib0270","doi-asserted-by":"crossref","first-page":"648","DOI":"10.4161\/auto.6.5.12047","article-title":"Impaired autophagosomes and lysosomes in neuronopathic Gaucher disease","volume":"6","author":"Sun","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.molmed.2011.05.003_bib0275","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/ng1292-318","article-title":"Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain","volume":"2","author":"Soong","year":"1992","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2011.05.003_bib0280","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0197-4580(03)00037-X","article-title":"Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease","volume":"25","author":"Simon","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.molmed.2011.05.003_bib0285","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.bbadis.2008.11.007","article-title":"Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis","volume":"1792","author":"Banerjee","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molmed.2011.05.003_bib0290","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1074\/jbc.M710012200","article-title":"Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain","volume":"283","author":"Devi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2011.05.003_bib0295","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neulet.2010.09.061","article-title":"Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo","volume":"486","author":"Chinta","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.molmed.2011.05.003_bib0300","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/nrm2546","article-title":"One step at a time: endoplasmic reticulum-associated degradation","volume":"9","author":"Vembar","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molmed.2011.05.003_bib0305","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/ana.20939","article-title":"The proteasomal inhibition model of Parkinson's disease: \u201cboon or bust\u201d?","volume":"60","author":"Beal","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molmed.2011.05.003_bib0310","doi-asserted-by":"crossref","first-page":"8189","DOI":"10.1523\/JNEUROSCI.2218-08.2008","article-title":"Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies","volume":"28","author":"Bedford","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2011.05.003_bib0315","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1073\/pnas.0610548104","article-title":"Structure of the Parkin in-between-ring domain provides insights for E3-ligase dysfunction in autosomal recessive Parkinson's disease","volume":"104","author":"Beasley","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2011.05.003_bib0320","doi-asserted-by":"crossref","first-page":"e12962","DOI":"10.1371\/journal.pone.0012962","article-title":"Mutant Parkin impairs mitochondrial function and morphology in human fibroblasts","volume":"5","author":"Grunewald","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2011.05.003_bib0325","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1093\/hmg\/ddq292","article-title":"Interaction between parkin and mutant glucocerebrosidase variants: a possible link between Parkinson disease and Gaucher disease","volume":"19","author":"Ron","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2011.05.003_bib0330","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev.cellbio.042308.113313","article-title":"alpha-Synuclein: membrane interactions and toxicity in Parkinson's disease","volume":"26","author":"Auluck","year":"2010","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.molmed.2011.05.003_bib0335","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1016\/j.bpj.2008.12.3940","article-title":"The influence of vesicle size and composition on alpha-synuclein structure and stability","volume":"96","author":"Kjaer","year":"2009","journal-title":"Biophys. J."},{"key":"10.1016\/j.molmed.2011.05.003_bib0340","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1242\/jcs.001073","article-title":"Altered dynamics of the lysosomal receptor for chaperone-mediated autophagy with age","volume":"120","author":"Kiffin","year":"2007","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.molmed.2011.05.003_bib0345","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ymgme.2007.08.001","article-title":"Secondary sphingolipid accumulation in a macrophage model of Gaucher disease","volume":"92","author":"Hein","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.molmed.2011.05.003_bib0350","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1194\/jlr.M800092-JLR200","article-title":"Lipid composition of microdomains is altered in a cell model of Gaucher disease","volume":"49","author":"Hein","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.molmed.2011.05.003_bib0355","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.neuro.2009.06.009","article-title":"alpha-Synuclein\u2013glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism","volume":"30","author":"Manning-Bog","year":"2009","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.molmed.2011.05.003_bib0360","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S1474-4422(10)70213-1","article-title":"Are synucleinopathies prion-like disorders?","volume":"9","author":"Angot","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.molmed.2011.05.003_bib0365","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ymgme.2010.08.004","article-title":"Gaucher disease and parkinsonism, a molecular link theory","volume":"101","author":"Goldin","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.molmed.2011.05.003_bib0370","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1600-0854.2004.00247.x","article-title":"Exosomes: a bubble ride for prions?","volume":"6","author":"Fevrier","year":"2005","journal-title":"Traffic"},{"key":"10.1016\/j.molmed.2011.05.003_bib0375","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/abbs\/gmq028","article-title":"Cellular prion protein released on exosomes from macrophages binds to Hsp70","volume":"42","author":"Wang","year":"2010","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"10.1016\/j.molmed.2011.05.003_bib0380","doi-asserted-by":"crossref","first-page":"19473","DOI":"10.1073\/pnas.1003308107","article-title":"Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage","volume":"107","author":"Mistry","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2011.05.003_bib0385","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00018-010-0565-6","article-title":"Chaperone-mediated autophagy: machinery, regulation and biological consequences","volume":"68","author":"Li","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.molmed.2011.05.003_bib0390","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.brainresbull.2009.06.018","article-title":"Neuropathology of Lewy body disorders","volume":"80","author":"Kovari","year":"2009","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.molmed.2011.05.003_bib0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2010.11.003","article-title":"Autophagy and misfolded proteins in neurodegeneration","author":"Metcalf","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.molmed.2011.05.003_bib0400","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/ncb0910-814","article-title":"Eaten alive: a history of macroautophagy","volume":"12","author":"Yang","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2011.05.003_bib0405","doi-asserted-by":"crossref","first-page":"9987","DOI":"10.1074\/jbc.M307905200","article-title":"Determination of four sequential stages during microautophagy in vitro","volume":"279","author":"Kunz","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2011.05.003_bib0410","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.devcel.2010.12.003","article-title":"Microautophagy of cytosolic proteins by late endosomes","volume":"20","author":"Sahu","year":"2011","journal-title":"Dev. Cell"},{"key":"10.1016\/j.molmed.2011.05.003_bib0415","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ceb.2010.10.009","article-title":"Chaperone-mediated autophagy in protein quality control","volume":"23","author":"Arias","year":"2010","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.molmed.2011.05.003_bib0420","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.molcel.2010.08.004","article-title":"Identification of regulators of chaperone-mediated autophagy","volume":"39","author":"Bandyopadhyay","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2011.05.003_bib0425","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1083\/jcb.201008084","article-title":"Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL","volume":"191","author":"Jin","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molmed.2011.05.003_bib0430","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.4161\/auto.6.8.13426","article-title":"p62\/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both","volume":"6","author":"Narendra","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.molmed.2011.05.003_bib0435","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1749-6632.2009.04365.x","article-title":"Parkinson's disease: the dual hit theory revisited","volume":"1170","author":"Hawkes","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.molmed.2011.05.003_bib0440","doi-asserted-by":"crossref","first-page":"12571","DOI":"10.1073\/pnas.0906759106","article-title":"Is Parkinson's disease a prion disorder?","volume":"106","author":"Olanow","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molmed.2011.05.003_bib0445","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.0903691106","article-title":"Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein","volume":"106","author":"Desplats","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491411000803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491411000803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T08:54:22Z","timestamp":1543568062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491411000803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":89,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S1471491411000803"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2011.05.003","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}